Jan D’Alvise | President and Chief Executive Officer |
Pierre Lemieux | Chief Operating Officer, Canada, Chief Scientific Officer, and Co-Founder |
George Kottayil | Chief Operating Officer, U.S. |
Brian Ford | Chief Financial Officer |
Prashant Kohli | VP of Commercial Operations |
David Waldman | Investor Relations |
Nicole Kaufman | Blackridge Capital |
Jim Caldwell | Analyst |
Sean Canavan | Analyst |
Sahil Khathmi | Analyst |
Good day, ladies and gentlemen, and welcome to the Acasti Pharma Second Quarter 2022, earnings call. At this time all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, David Waldmann of Investor Relations. Sir, the floor is yours.
Thank you.